| |
Symbol |
Name |
Market Cap |
Exchange |
Z-Score |
 | ABT  | Abbott Laboratories | $76.1B | NYSE | 2.784 |
| ACST | Acasti Pharma Inc | $13.5M | NASDAQ | |
| ACET | Aceto Corporation | $424.6M | NASDAQ | 3.5928 |
| ADMP | Adamis Pharmaceuticals Corp | $78.3M | NASDAQ | 1.4017 |
| AEGR | Aegerion Pharmaceuticals, Inc. | $56.6M | NASDAQ | -0.3099 |
| AKRX | Akorn, Inc. | $4.2B | NASDAQ | 2.6767 |
| AMAG | AMAG Pharmaceuticals, Inc. | $667.9M | NASDAQ | 0.73 |
| FOLD | Amicus Therapeutics, Inc. | $1.0B | NASDAQ | 0.1917 |
| AMPH | Amphastar Pharmaceuticals Inc | $743.8M | NASDAQ | 5.0177 |
| APRI | Apricus Biosciences Inc | $14.0M | NASDAQ | -94.1076 |
| AQXP | Aquinox Pharmaceuticals Inc | $251.4M | NASDAQ | 17.1159 |
| ARLZ | Aralez Pharmaceuticals Inc | $102.7M | NASDAQ | |
| AZN | AstraZeneca plc (ADR) | $42.8B | NYSE | 0.9968 |
| BDSI | BioDelivery Sciences International, Inc. | $101.8M | NASDAQ | -6.6739 |
| BLFS | BioLife Solutions Inc | $29.1M | NASDAQ | -7.7016 |
| BMY | Bristol-Myers Squibb Co | $90.8B | NYSE | 5.3617 |
| CBM | Cambrex Corporation | $1.7B | NYSE | 6.8941 |
| CTLT | Catalent Inc | $4.0B | NYSE | 1.0391 |
| CLRB | Cellectar Biosciences Inc | $17.2M | NASDAQ | 1.9188 |
| CPHR | Cipher Pharmaceuticals Inc | $77.8M | NASDAQ | |
| COLL | Collegium Pharmaceutical Inc | $221.7M | NASDAQ | 4.9566 |
| CLCD | CoLucid Pharmaceuticals Inc | $895.6M | NASDAQ | 11.1653 |
| CXRX | Concordia International Corp | $76.1M | NASDAQ | |
| CORT | Corcept Therapeutics Incorporated | $1.2B | NASDAQ | 21.6297 |
| CORI | Corium International Inc | $165.1M | NASDAQ | -1.2208 |
| RDY | Dr.Reddy's Laboratories Ltd (ADR) | $6.9B | NYSE | 5.615 |
| LLY | Eli Lilly and Co | $88.2B | NYSE | 3.4531 |
| EVOK | Evoke Pharma Inc | $39.5M | NASDAQ | -2.8642 |
| EYEG | Eyegate Pharmaceuticals Inc | $18.5M | NASDAQ | -9.8494 |
| GALE | Galena Biopharma Inc | $21.2M | NASDAQ | -5.9726 |
| GSK | GlaxoSmithKline plc (ADR) | $107.1B | NYSE | 1.1744 |
| HSGX | Histogenics Corp | $22.3M | NASDAQ | -5.564 |
| HZNP | Horizon Pharma PLC | $1.7B | NASDAQ | 0.5876 |
| IBIO | Ibio Inc | $33.9M | NYSE MKT | -0.541 |
| IMNP | Immune Pharmaceuticals Inc | $23.1M | NASDAQ | -1.9 |
| IPXL | Impax Laboratories Inc | $1.3B | NASDAQ | 1.0223 |
| INNL | Innocoll Holdings PLC | $64.1M | NASDAQ | -6.2319 |
| INVA | Innoviva Inc | $1.3B | NASDAQ | 2.0301 |
| IPCI | IntelliPharmaCeutics Intl Inc (USA) | $52.6M | NASDAQ | -5.1953 |
| JNJ | Johnson & Johnson | $336.3B | NYSE | 4.7832 |
| JNP | Juniper Pharmaceuticals Inc | $47.7M | NASDAQ | -2.5562 |
| LCI | Lannett Company, Inc. | $841.7M | NYSE | 1.3262 |
| MRNS | Marinus Pharmaceuticals Inc | $26.0M | NASDAQ | -2.6544 |
| MRK | Merck & Co., Inc. | $174.8B | NYSE | 3.2239 |
| MBRX | Moleculin Biotech Inc | $13.9M | NASDAQ | 6.1949 |
| MYL | Mylan NV | $19.8B | NASDAQ | 2.0086 |
| NAII | Natural Alternatives International, Inc. | $67.0M | NASDAQ | 5.2017 |
| NEOS | Neos Therapeutics Inc | $121.3M | NASDAQ | -2.006 |
| NEOT | Neothetics Inc | $29.7M | NASDAQ | 2.0834 |
| CUR | Neuralstem, Inc. | $47.7M | NASDAQ | -8.0067 |
| NVS | Novartis AG (ADR) | $190.7B | NYSE | 2.2191 |
| NVO | Novo Nordisk A/S (ADR) | $80.0B | NYSE | 7.2506 |
| OPK | Opko Health Inc. | $4.0B | NASDAQ | 3.8091 |
| PCRX | Pacira Pharmaceuticals Inc | $1.9B | NASDAQ | 6.6106 |
| PTHN | Patheon NV | $3.7B | NYSE | 1.2425 |
| PTX | Pernix Therapeutics Holdings Inc | $55.6M | NASDAQ | -1.1198 |
| PFE | Pfizer Inc. | $197.1B | NYSE | 2.0668 |
| SGNT | Sagent Pharmaceuticals Inc | $346.4M | NASDAQ | 2.9783 |
| SNY | Sanofi SA (ADR) | $62.5B | NYSE | 1.119 |
| SCLN | SciClone Pharmaceuticals, Inc. | $484.4M | NASDAQ | 11.773 |
| SCYX | SCYNEXIS Inc | $43.6M | NASDAQ | -1.4089 |
| SHPG | Shire PLC (ADR) | $54.8B | NASDAQ | 1.1194 |
| SPHS | Sophiris Bio Inc | $77.2M | NASDAQ | |
| TARO | Taro Pharmaceutical Industries Ltd. | $4.9B | NYSE | 16.0755 |
| TLGT | Teligent Inc | $471.0M | NASDAQ | 2.4269 |
| TTPH | Tetraphase Pharmaceuticals Inc | $291.0M | NASDAQ | 14.2576 |
| TEVA | Teva Pharmaceutical Industries Ltd (ADR) | $32.2B | NYSE | 0.5715 |
| TBPH | Theravance Biopharma Inc | $1.8B | NASDAQ | 3.0191 |
| UG | United-Guardian, Inc. | $64.7M | NASDAQ | 33.9864 |
| VRX | Valeant Pharmaceuticals Intl Inc | $4.6B | NYSE | 0.1617 |
= link to the company website, 
